Job Watch
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity PA-20-047 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) to develop and validate next-generation single cell analysis technologies and tools. The purpose is to foster the commercialization of innovative single cell analysis technologies for their broad use in biomedical research. The novel single-cell analysis technologies will aid in obtaining a fine-grained and dynamic view of heterogeneous cellular states and intercellular interactions, thereby providing new mechanistic insight into biological processes in health and disease. Applications should define the current state of technologies and tools as a benchmark against which the new approach(es) will be measured. The new approach(es) should provide substantially improved performance in sensitivity, selectivity, spatiotemporal resolution, scalability, multiplexing capability, or non-destructive analysis of molecular or functional measures of single cells. A companion FOA to support STTR Grants is also available see PA-xx-XXX.
Categories: Job Watch, Literature Watch
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity PA-20-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Small Business Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) to develop and validate next-generation single cell analysis technologies and tools. The purpose is to foster the commercialization of innovative single cell analysis technologies for their broad use in biomedical research. The novel single-cell analysis technologies will aid in obtaining a fine-grained and dynamic view of heterogeneous cellular states and intercellular interactions, thereby providing new mechanistic insight into biological processes in health and disease. Applications should define the current state of technologies and tools as a benchmark against which the new approach(es) will be measured. The new approach(es) should provide substantially improved performance in sensitivity, selectivity, spatiotemporal resolution, scalability, multiplexing capability, or non-destructive analysis of molecular or functional measures of single cells.
Categories: Job Watch, Literature Watch
CK Group: Senior Bioinformatistician
Competitive:
CK Group:
Emily Mills at CK Technical is recruiting for a Senior Bioinformatistician to join a clinical stage, biopharmaceutical company at their site based in Cambridge on...
Cambridge
Categories: Job Watch
F. Hoffmann-La Roche AG: (Principal / Senior) or Biomedical Data Standards Specialist - Controlled Terminology
F. Hoffmann-La Roche AG:
Data have the power to answer more than one question and enable multiple discoveries, but only if Findable, Accessible, Interoperable, and Reusable (
Switzerland (CH)
Categories: Job Watch
F. Hoffmann-La Roche AG: (Principal / Senior) or Biomedical Data Standards Specialist - Data Collection
F. Hoffmann-La Roche AG:
Data have the power to answer more than one question and enable multiple discoveries, but only if Findable, Accessible, Interoperable, and Reusable (
Switzerland (CH)
Categories: Job Watch
Addition of SBIR Direct-to-Phase II Program to NINDS RFA-NS-18-012, "Translational Neural Devices (U44 Clinical Trial Required)"
Notice NOT-NS-20-034 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Notice NOT-NS-20-033 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Notice NOT-NS-20-032 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest: Countermeasures Against Chemical Threats (CounterACT) U54 Centers of Excellence will only support targeted chemical threats of interest
Notice NOT-NS-20-031 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest: Administrative Supplements to Promote and Expand into the Research and Development of Medical Countermeasures Against Chemical Threats
Notice NOT-NS-20-030 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest: Administrative Supplements for Existing NIH Countermeasures Against Chemical Threats (CounterACT) Program Research Grants and Cooperative Agreement Awards
Notice NOT-NS-20-029 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIDCR Participation in PAR-19-384 "Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)"
Notice NOT-DE-20-005 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIDCR Participation in PAR-19-373 "Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)"
Notice NOT-DE-20-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Biomarkers and Biotypes of Drug Addiction
Notice NOT-DA-20-012 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Preclinical and Clinical Studies of the Interactions of Opioids and Stimulants
Notice NOT-DA-20-007 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIAAA Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)"
Notice NOT-AA-19-034 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): De-implementation of Ineffective or Low-value Clinical Practices along the Cancer Care Continuum
Notice NOT-CA-20-021 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
SRG: Field Application Scientist
Negotiable:
SRG:
Field Application Scientist (FAS)
South Cambridgeshire
UK based travel
Cambridge, England
Categories: Job Watch
Biomarker Data Specialist II - Seattle Genetics, Inc. - Bothell, WA
Internal stakeholders may include Clinical Pharmacologists, Biomarker & Bioinformatics scientists, Clinical Project Managers and others.
From Seattle Genetics, Inc. - Sat, 04 Jan 2020 00:17:00 GMT - View all Bothell, WA jobs
From Seattle Genetics, Inc. - Sat, 04 Jan 2020 00:17:00 GMT - View all Bothell, WA jobs
Categories: Job Watch
F. Hoffmann-La Roche AG: (Principal / Senior) or Biomedical Data Standards Specialist - Controlled Terminology
F. Hoffmann-La Roche AG:
Data have the power to answer more than one question and enable multiple discoveries, but only if Findable, Accessible, Interoperable, and Reus
Switzerland (CH)
Categories: Job Watch
Pages
